These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7907282)

  • 1. The consequences of long-term antipsychotic drug administration on basal ganglia neuronal function in laboratory animals.
    See RE; Chapman MA
    Crit Rev Neurobiol; 1994; 8(1-2):85-124. PubMed ID: 7907282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipsychotic drugs: differential effects on dopamine neurons in basal ganglia and mesocortex following chronic administration in human and nonhuman primates.
    Roth RH; Bacopoulos NG; Bustos G; Redmond DE
    Adv Biochem Psychopharmacol; 1980; 24():513-20. PubMed ID: 6105797
    [No Abstract]   [Full Text] [Related]  

  • 3. Basal ganglia volumes in drug-naive first-episode schizophrenia patients before and after short-term treatment with either a typical or an atypical antipsychotic drug.
    Glenthoj A; Glenthoj BY; Mackeprang T; Pagsberg AK; Hemmingsen RP; Jernigan TL; Baaré WF
    Psychiatry Res; 2007 Apr; 154(3):199-208. PubMed ID: 17360162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do neurotensin receptor agonists represent a novel class of antipsychotic drugs?
    Cáceda R; Kinkead B; Nemeroff CB
    Semin Clin Neuropsychiatry; 2003 Apr; 8(2):94-108. PubMed ID: 12728409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are movement disorders the most serious side effects of maintenance therapy with antipsychotic drugs?
    Lidsky TI; Labuszewski T; Levine FM
    Biol Psychiatry; 1981 Dec; 16(12):1189-94. PubMed ID: 6130799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioural effects of chronic haloperidol and risperidone treatment in rats.
    Karl T; Duffy L; O'brien E; Matsumoto I; Dedova I
    Behav Brain Res; 2006 Aug; 171(2):286-94. PubMed ID: 16697060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose and behavioral context dependent inhibition of movement and basal ganglia neural activity by Delta-9-tetrahydrocannabinol during spontaneous and treadmill locomotion tasks in rats.
    Shi LH; Luo F; Woodward DJ; Chang JY
    Synapse; 2005 Jan; 55(1):1-16. PubMed ID: 15499609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Region-specific induction of deltaFosB by repeated administration of typical versus atypical antipsychotic drugs.
    Atkins JB; Chlan-Fourney J; Nye HE; Hiroi N; Carlezon WA; Nestler EJ
    Synapse; 1999 Aug; 33(2):118-28. PubMed ID: 10400890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin receptors: their key role in drugs to treat schizophrenia.
    Meltzer HY; Li Z; Kaneda Y; Ichikawa J
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Oct; 27(7):1159-72. PubMed ID: 14642974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PDE10A inhibitors: an assessment of the current CNS drug discovery landscape.
    Chappie T; Humphrey J; Menniti F; Schmidt C
    Curr Opin Drug Discov Devel; 2009 Jul; 12(4):458-67. PubMed ID: 19562642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antipsychotic drug actions on gene modulation and signaling mechanisms.
    Molteni R; Calabrese F; Racagni G; Fumagalli F; Riva MA
    Pharmacol Ther; 2009 Oct; 124(1):74-85. PubMed ID: 19540875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of divalproex and atypical antipsychotic drugs on dopamine and acetylcholine efflux in rat hippocampus and prefrontal cortex.
    Huang M; Li Z; Ichikawa J; Dai J; Meltzer HY
    Brain Res; 2006 Jul; 1099(1):44-55. PubMed ID: 16824491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuronal circuitry and synaptic connectivity of the basal ganglia.
    Smith Y; Shink E; Sidibé M
    Neurosurg Clin N Am; 1998 Apr; 9(2):203-22. PubMed ID: 9556359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signaling in the basal ganglia: postsynaptic and presynaptic mechanisms.
    Fisone G; Håkansson K; Borgkvist A; Santini E
    Physiol Behav; 2007 Sep; 92(1-2):8-14. PubMed ID: 17585965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophysiological effects of SKF 38393 in rats with reserpine treatment and 6-hydroxydopamine-induced nigrostriatal lesions reveal two types of plasticity in D1 dopamine receptor modulation of basal ganglia output.
    Huang KX; Walters JR
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1434-43. PubMed ID: 7996456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simulation of GABA function in the basal ganglia: computational models of GABAergic mechanisms in basal ganglia function.
    Wickens JR; Arbuthnott GW; Shindou T
    Prog Brain Res; 2007; 160():313-29. PubMed ID: 17499122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional anatomy of thalamus and basal ganglia.
    Herrero MT; Barcia C; Navarro JM
    Childs Nerv Syst; 2002 Aug; 18(8):386-404. PubMed ID: 12192499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The neurophysiological correlates of motor tics following focal striatal disinhibition.
    McCairn KW; Bronfeld M; Belelovsky K; Bar-Gad I
    Brain; 2009 Aug; 132(Pt 8):2125-38. PubMed ID: 19506070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of second-generation antipsychotics on the use of antiparkinson agents in nursing homes and assisted-living facilities.
    Touré JT; Brandt NJ; Limcangco MR; Briesacher BA
    Am J Geriatr Pharmacother; 2006 Mar; 4(1):25-35. PubMed ID: 16730618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.